Profile picture

Doctor Ana Sofia Martinho

University Hospitals of Coimbra, Coimbra (Portugal)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Ventricular tachycardia ablation before an implantable cardioverter defibrillator in secondary prevention: is always the best option?
Presentation
Ventricular tachycardia ablation before an implantable cardioverter defibrillator in secondary prevention: is always the best option?
Prognostic nutritional index: an undervalued and underused prognostic marker in acute heart failure patients
Presentation
Prognostic nutritional index: an undervalued and underused prognostic marker in acute heart failure patients
Malnutrition: a mascaraed and underused prognostic marker in coronary patients
Presentation
Malnutrition: a mascaraed and underused prognostic marker in coronary patients
Usefulness of the physiological single chamber pacemaker VDD in elderly patients with normal sinus rhythm
Presentation
Usefulness of the physiological single chamber pacemaker VDD in elderly patients with normal sinus rhythm
Ten years of experience in pre-transplant patients from an advanced heart failure center - when is the best time to step in?
Presentation
Ten years of experience in pre-transplant patients from an advanced heart failure center - when is the best time to step in?
Ten years of experience in pre-transplant patients from an advanced heart failure center - when is the best time to step in?
Presentation
Ten years of experience in pre-transplant patients from an advanced heart failure center - when is the best time to step in?
Strauss formula: a great and easy tool to manage congestion in acute heart failure
Presentation
Strauss formula: a great and easy tool to manage congestion in acute heart failure
Left ventricular reverse remodeling and angiotensin ii receptor blocker neprilysin inhibitor - a real-world data
Presentation
Left ventricular reverse remodeling and angiotensin ii receptor blocker neprilysin inhibitor - a real-world data
Real-world experience with angiotensin ii receptor blocker neprilysin inhibitor: reverse remodelling is the norm
Presentation
Real-world experience with angiotensin ii receptor blocker neprilysin inhibitor: reverse remodelling is the norm

ESC 365 is supported by